Oxfam India mounts campaign to protect affordable drugsBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g7568 (Published 09 December 2014) Cite this as: BMJ 2014;349:g7568
- Susan Mayor
Oxfam India has launched a campaign to protect India’s intellectual property system that enables production of affordable drugs after US authorities have started talks with Indian government officials to review current regulations.1
The campaign, “Save our Medicines,” is collecting signatories to a petition calling on the US government and drug companies to stop putting pressure on India to change its laws on intellectual property. These enable Indian companies to produce generic drugs if patented versions cost more than patients can afford.
“The system has fostered robust generic competition, which slashes the prices of medicines—by more than 90% in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial